35 related articles for article (PubMed ID: 14620853)
21. Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery: building chiral technology toolboxes.
McConnell O; Bach A; Balibar C; Byrne N; Cai Y; Carter G; Chlenov M; Di L; Fan K; Goljer I; He Y; Herold D; Kagan M; Kerns E; Koehn F; Kraml C; Marathias V; Marquez B; McDonald L; Nogle L; Petucci C; Schlingmann G; Tawa G; Tischler M; Williamson RT; Sutherland A; Watts W; Young M; Zhang MY; Zhang Y; Zhou D; Ho D
Chirality; 2007 Sep; 19(9):658-82. PubMed ID: 17390370
[TBL] [Abstract][Full Text] [Related]
22. Bioseparations.
Lightfoot EN; Moscariello JS
Biotechnol Bioeng; 2004 Aug; 87(3):259-73. PubMed ID: 15281101
[TBL] [Abstract][Full Text] [Related]
23. Application issues in bioanalytical method validation, sample analysis and data reporting.
Dadgar D; Burnett PE; Choc MG; Gallicano K; Hooper JW
J Pharm Biomed Anal; 1995 Feb; 13(2):89-97. PubMed ID: 7766728
[TBL] [Abstract][Full Text] [Related]
24. Chromatographic Procedures in a Regulated Environment.
Tougas TP
Adv Chromatogr; 2011; 49():341-64. PubMed ID: 26434241
[No Abstract] [Full Text] [Related]
25. Lifetime and Aging of Chromatography Resins during Biopharmaceutical Manufacture.
Nweke MC; Rathore AS; Bracewell DG
Trends Biotechnol; 2018 Oct; 36(10):992-995. PubMed ID: 29370932
[TBL] [Abstract][Full Text] [Related]
26. Place of chromatography in the separation and purification of proteins produced from cultured cells.
Sene C; Boschetti E
Adv Biotechnol Processes; 1988; 8():205-40. PubMed ID: 3052498
[No Abstract] [Full Text] [Related]
27. Introduction to chromatography.
Janson JC; Jönsson JA
Methods Biochem Anal; 2011; 54():25-50. PubMed ID: 21954773
[No Abstract] [Full Text] [Related]
28. Conventional chromatography.
Simpson JM
Bioprocess Technol; 1994; 18():209-58. PubMed ID: 7764171
[No Abstract] [Full Text] [Related]
29. Current issues in validation of chromatography.
Sofer G
Dev Biol (Basel); 2003; 113():61-4. PubMed ID: 14620853
[TBL] [Abstract][Full Text] [Related]
30. Process scale considerations in evaluation studies and scale-up.
Walter JK; Werz W; Berthold W
Dev Biol Stand; 1996; 88():99-108. PubMed ID: 9119169
[TBL] [Abstract][Full Text] [Related]
31. Risk reduction in biotherapeutic products.
Ill CR; Dehghani H
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):296-304. PubMed ID: 19333875
[TBL] [Abstract][Full Text] [Related]
32. Systematical approach of formulation and process development using roller compaction.
Teng Y; Qiu Z; Wen H
Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
[TBL] [Abstract][Full Text] [Related]
33. Protein purification using chromatography: selection of type, modelling and optimization of operating conditions.
Asenjo JA; Andrews BA
J Mol Recognit; 2009; 22(2):65-76. PubMed ID: 18546092
[TBL] [Abstract][Full Text] [Related]
34. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.
Viswanathan CT; Bansal S; Booth B; DeStefano AJ; Rose MJ; Sailstad J; Shah VP; Skelly JP; Swann PG; Weiner R
Pharm Res; 2007 Oct; 24(10):1962-73. PubMed ID: 17458684
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
